Liu et al. found that PI3K/AKT/ mTOR signaling and autophagic activity were enhanced markedly in the IM-resistant CML cell line K562 (K562RIMT). Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.